Theodore J. Witek, Jr
2014
In 2014, Theodore J. Witek, Jr earned a total compensation of $1.5M as Senior Vice President and Chief Scientific Officer Clinical and Medical Affairs at Innoviva.
Compensation breakdown
| Non-Equity Incentive Plan | $140,876 |
|---|---|
| Option Awards | $1,156,400 |
| Salary | $192,917 |
| Other | $500 |
| Total | $1,490,693 |
Witek received $1.2M in option awards, accounting for 78% of the total pay in 2014.
Witek also received $140.9K in non-equity incentive plan, $192.9K in salary and $500 in other compensation.
Rankings
In 2014, Theodore J. Witek, Jr's compensation ranked 5,776th out of 13,032 executives tracked by ExecPay. In other words, Witek earned more than 55.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,776 out of 13,032 | 56th |
Division Manufacturing | 2,073 out of 4,965 | 58th |
Major group Chemicals And Allied Products | 697 out of 1,690 | 59th |
Industry group Drugs | 542 out of 1,369 | 60th |
Industry Pharmaceutical Preparations | 417 out of 1,042 | 60th |
Source: SEC filing on March 25, 2016.
Witek's colleagues
We found six more compensation records of executives who worked with Theodore J. Witek, Jr at Innoviva in 2014.
2014
Rick Winningham
Innoviva
Chief Executive Officer
2014
Michael Aguiar
Innoviva
Chief Executive Officer
2014
Mathai Mammen
Innoviva
Former Senior Vice President, Research & Development
2014
Leonard Blum
Innoviva
Former Senior Vice President and Chief Commercial Officer
2014
Eric d'Esparbes
Innoviva
Chief Financial Officer
2014
George Abercrombie
Innoviva